![](/img/cover-not-exists.png)
A liposome-based platform, VacciMax®, and its modified water-free platform DepoVax™ enhance efficacy of in vivo nucleic acid delivery
Mohan Karkada, Genevieve M. Weir, Tara Quinton, Antar Fuentes-Ortega, Marc MansourVolume:
28
Year:
2010
Language:
english
DOI:
10.1016/j.vaccine.2010.07.025
File:
PDF, 218 KB
english, 2010